Frank C Passero Jr. and Muhammad Wasif Saif*
Section of GI Cancers and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA, USA
- *Corresponding Author:
- Muhammad Wasif Saif
Director, Section of GI Cancers and Experimental Therapeutics
Tufts University School of Medicine
800 Washington Street, Boston, MA 02111, USA
Tel +1 6176365627
Fax +1 6176368535
E-mail wsaif@tuftsmedicalcenter.org
Received March 06th, 2015 – Accepted March 11th, 2015
Kidney disease is a complication that is observed in 10%?30% of patients infected with human immunodeficiency virus (HIV), and is a common cause of morbidity and mortality [1],[2]. In Mexico, an estimated 175,093 HIV-infected individuals are included in national registries [3]. The increased survival of HIV-infected patients has changed the course of the disease, with renal complications related to HIV now the fourth most common cause of mortality [4].
